What is a paracetamol project report?
A paracetamol project report is a detailed project report (DPR) for a bulk drug plant that converts para aminophenol into pharmacopoeia-grade paracetamol API, also called acetaminophen. It covers the process, machinery, raw materials, licences, project cost, means of finance, five-year projections, DSCR and break-even that a lender or investor reviews before funding the plant.
Promoters use it to fix capacity and raise a term loan; banks and investors use it to check whether the plant can meet drug regulations and still repay.
Also known as: project report on paracetamol, paracetamol business plan, paracetamol API plant DPR, acetaminophen manufacturing project report.
Paracetamol manufacturing plant cost and economics
Our sample report models a 2,300 kg per day API plant that buys para aminophenol and acetylates it on site. It runs 330 days a year, starts at 60% capacity and reaches 80% in Year 5, selling at ₹386 per kg ex-GST.
Plant and machinery is about half of the project cost. Land and building are the next biggest items, because a drug plant needs separate stores, a quality control laboratory and a controlled area for drying, milling and packing.
| Land and site development | 144.67 |
|---|---|
| Building and civil works | 347.23 |
| Plant and machinery | 720.09 |
| Other fixed assets | 84.61 |
| Contingencies | 53.37 |
| Preliminary and pre-operative | 33.75 |
| Working capital margin | 67.73 |
| Total | 1,451.45 |
| Promoter's contribution (25%) | 362.86 |
|---|---|
| Term loan from bank (75%) | 1,088.59 |
| Cash credit limit (separate) | 203.19 |
| Total project cost | 1,451.45 |
DSCR (debt service coverage ratio) is the cash the plant earns divided by the loan instalments due. In the sample it averages 1.38, with the lowest value of 1.22 in Year 2, when full principal repayment starts. Break-even in Year 3 is 43.3% of capacity, against 70% planned for that year.
Term loan at 10.5% with a 6-month moratorium and 54 monthly instalments. All figures are illustrative.
Paracetamol manufacturing process
Paracetamol is made in batches. The chemistry is a single reaction, but most of the work goes into purification, because the API must pass colour, assay and impurity tests set by the pharmacopoeia.
- Acetylation
Para aminophenol is charged into a glass lined reactor and reacted with acetic anhydride, which forms crude paracetamol and acetic acid as a by-product.
- Crystallisation
The batch is cooled under control so crude paracetamol crystallises out; the rate of cooling decides crystal size and how well it filters.
- Centrifuging
Crystals are separated in a centrifuge, and the mother liquor goes to recovery so that acetic acid and dissolved product are not lost.
- Carbon treatment and recrystallisation
The crude is redissolved, treated with activated carbon to remove coloured oxidation products, filtered hot and crystallised again.
- Drying
Wet cake is dried in a fluid bed dryer to the moisture limit in the monograph, without overheating the product.
- Milling, testing and packing
Dry powder is milled and sifted to the particle size buyers ask for. Each batch is tested and packed in lined drums with a certificate of analysis.
Which route should a new paracetamol plant use?
Every route ends with the same acetylation step. The difference is whether you buy para aminophenol or make it yourself, which changes capital cost, hazards and effluent far more than it changes the final product.
| Buy para aminophenol and acetylate | The route in our sample. Lowest capital cost and simplest approvals, but margin rises and falls with the price of bought para aminophenol. |
|---|---|
| Nitrobenzene route | Nitrobenzene is hydrogenated in sulphuric acid to para aminophenol, which is then acetylated. Needs hydrogen handling and catalyst recovery; aniline comes out as a by-product. |
| Para nitrochlorobenzene route | Hydrolysis gives para nitrophenol, which is reduced to para aminophenol and acetylated. More steps and more effluent to treat. |
| Phenol route | Phenol is nitrated, the para isomer is separated and reduced, then acetylated. Isomer separation adds equipment and waste. |
Start simple, integrate later: most first projects begin with bought para aminophenol. Keep space in the layout for a backward integration stage once buyers and cash flow are in place.
Raw materials for paracetamol
Para aminophenol is the main cost. It darkens when exposed to air and light, so it is stored sealed and used on a first-in, first-out basis; off-colour stock costs extra carbon and recrystallisation. Raw materials take 51.3% of sales in the sample.
| Raw material | Share of cost | Year 3 (₹ lakh) |
|---|---|---|
| Para aminophenol | 70% | 737.12 |
| Acetic anhydride | 22% | 231.67 |
| Solvents and activated carbon | 8% | 84.24 |
| Total | 100% | 1,053.03 |
Sample report values at 70% capacity. Packing, power and labour are costed separately.
Machinery for a paracetamol API plant
Glass lined reactors are the largest machinery item, because acetic acid and acetic anhydride attack plain steel. Contact parts elsewhere are usually stainless steel so that no metal traces reach the API.
| Machine | What it does | Sample cost (₹ lakh) |
|---|---|---|
| Glass lined reactors | Acetylation and redissolving | 216.03 |
| Centrifuges | Separate crystals from liquor | 108.01 |
| Solvent recovery system | Recovers acetic acid and solvents | 93.61 |
| Crystallisers | Controlled cooling of each batch | 86.41 |
| Fluid bed dryer | Dries wet cake to moisture limit | 86.41 |
| QC laboratory | Assay, impurity and release tests | 72.01 |
| Milling and sifting | Sets particle size for buyers | 57.61 |
| Total plant and machinery | 720.09 | |
Costs are the sample report's estimates for a 2,300 kg per day plant. Get current quotations before you finalise.
Manpower and utilities for a paracetamol plant
Power and fuel cost ₹162.12 lakh in Year 3 of the sample, about 7.9% of sales. Steam heats the reactors and dryer, chilled water drives crystallisation, and purified water is needed for cleaning and the final stages.
The sample plant employs 48 people. A drug plant needs more qualified staff than a chemical unit of the same size. Production, quality control and quality assurance must be headed by people with the qualifications the drug licence asks for.
| Category | Number | Monthly wage (₹) | Annual cost (₹ lakh) |
|---|---|---|---|
| Management, supervision and administration | 7 | 32,500 | 27.30 |
| Skilled workers and operators | 17 | 20,500 | 41.82 |
| Semi-skilled and unskilled workers | 24 | 13,500 | 38.88 |
| Total (Year 1) | 48 | 108.00 |
Licences and approvals to manufacture paracetamol
A paracetamol API plant is regulated twice over: as a drug manufacturer and as a synthetic organic chemical unit. Approvals take longer than for a formulation unit, so start them before you order machinery.
| Drug manufacturing licence | Apply in Form 24 to the State Drugs Control Department; the licence is granted in Form 25 under the Drugs Rules, 1945, after inspection of the premises |
|---|---|
| Good manufacturing practices | Revised Schedule M applies. The extension for manufacturers with turnover up to ₹250 crore ran to 31 December 2025, so a new plant should be designed to it from the start |
| Environmental clearance | Bulk drugs and intermediates fall under item 5(f), synthetic organic chemicals, of the EIA Notification, 2006, which needs prior clearance; drug formulations are excluded |
| Pollution board consent | Pharmaceuticals are in the CPCB Red category; consent to establish and to operate come from the State Pollution Control Board |
| Product standard | Each batch is tested to the Indian Pharmacopoeia monograph (IP 2026 is the 10th edition); export buyers may also ask for BP or USP grade |
| Business registration | Udyam and GST registration, factory licence and fire NOC, as for any plant |
Checked against official sources in October 2026. Rules change; confirm with the state authorities before you apply.
Market for paracetamol API in India
Paracetamol is among the most used medicines for pain and fever, so tablet, syrup and injection makers buy it all year, with peaks in fever and flu seasons. Buyers purchase on approved-vendor lists, which means a new plant sells on consistent quality and paperwork more than on price.
Para aminophenol has largely been imported. The Department of Pharmaceuticals' PLI list for bulk drugs (December 2022 update) includes para aminophenol projects of 13,500 MT and 12,000 MT of installed capacity. These could widen domestic supply of the key input.
- Tablet and syrup formulation units
- Contract and loan-licence manufacturers
- Pharmaceutical exporters
- Bulk drug traders and distributors
- Manufacturers supplying government and institutional tenders
Plan for vendor approval: a formulator usually tests your validation batches and audits the plant before placing regular orders. Budget for several months of slow sales after commissioning.
Mistakes that weaken a paracetamol project report
- Pricing the API at a peak
Paracetamol and para aminophenol prices swing with import supply. A report built on one good month overstates sales; test a price fall and a para aminophenol rise together.
- Assuming every batch passes first time
Colour and free para aminophenol limits are tight. Allow for batches that need a second recrystallisation, with the extra carbon, steam and time they use.
- Leaving out recovery of acetic acid and solvents
Acetylation produces acetic acid in every batch. Without a recovery system and its cost in the report, both raw material cost and effluent load are wrong.
- Ignoring the approval and vendor-qualification gap
Environmental clearance, the drug licence and buyer audits all come before regular sales. Interest and fixed costs for that period must be in the project cost.
How NPCS helps you set up a paracetamol plant
- Route and capacityCompare buying para aminophenol with backward integration, and size batches to your buyers.
- Plant and layoutReactor, centrifuge and dryer train, recovery system and a layout planned for revised Schedule M.
- Bank-ready project reportProjections, DSCR, sensitivity to para aminophenol price and working capital in your lender's format.
- Approvals roadmapSequence for environmental clearance, pollution consents and the Form 25 drug licence in your state.
NPCS's client list includes 4 assignments for paracetamol and 67 in pharmaceuticals, for promoters, banks and companies in India and abroad. The work is done by the NPCS project team, led by founder Ajay Kumar Gupta.
What's inside the paracetamol sample report
- Introduction
- Uses and applications
- Market potential
- Manufacturing process
- Raw materials
- Plant and machinery
- Land, building and utilities
- Manpower
- Licences and approvals
- Project cost and means of finance
- Working capital
- Projected profitability
- Cash flow statement
- Projected balance sheet
- Depreciation
- Term loan repayment
- Debt service coverage
- Break-even analysis
- Financial ratios
- Key assumptions
- Conclusion
- Monthly loan repayment schedule
18 pages, five-year projections, illustrative figures.
Open sample reportFree sample or a report for your project?
| What you get | Free sample | NPCS report for your project |
|---|---|---|
| Capacity and location | Typical unit | Your capacity, site and state |
| Figures | Illustrative | Built on current prices and quotations |
| Machinery suppliers and quotations | No | Yes |
| Market survey for your region | No | Yes |
| Bank or scheme format (PMEGP, term loan) | No | Yes |
| Use for a loan application | No | Yes |
What clients say about NPCS
4.7
264 Google reviews, as of 20 Oct 2026
Clients most often mention
- feasibility reports 18
- project report 16
- helpful for startups 15
- detailed reports 8
-
Excellent experience with Niir Project Consultancy Services. Their Techno-Economic Feasibility Reports are incredibly detailed and backed by solid market data.
Piyush Singh, Google review, 2026
-
Niir Project Consultancy Services offers excellent guidance for business setup. Their market survey and feasibility reports saved us a lot of time and helped us make informed decisions. Highly recommended
Saroj Yadav, Google review, 2026 View on Google
-
In an era of information overload, NIIR stands out for its precision. Their technical consultancy and market feasibility studies are world-class.
Shrishti Gautam, Google review, 2026
-
NIIR Project Consultancy Services provides useful books and reports for students, entrepreneurs, and small businesses. Their content is easy to understand and focuses on practical ideas for starting and managing industries. Overall, NIIR is helpful for learning about business and project planning.
Raj Yadav, Google review, 2026
Paracetamol project report: frequently asked questions
What is the paracetamol manufacturing plant cost in India?
Our sample report models a 2,300 kg per day paracetamol API plant at ₹1,451 lakh, including ₹720 lakh of plant and machinery, land, building and working capital margin. A plant that also makes its own para aminophenol costs far more, because it adds hydrogenation or nitration sections. Your report works out the cost for your capacity, route and site.
How is paracetamol manufactured?
Most Indian plants make paracetamol by acetylating para aminophenol with acetic anhydride in glass lined reactors. The crude product is crystallised, centrifuged, treated with activated carbon and recrystallised to remove colour and free para aminophenol. The wet crystals are then dried in a fluid bed dryer, milled, sifted and tested to the Indian Pharmacopoeia monograph before packing.
What raw materials are needed to make paracetamol?
Para aminophenol and acetic anhydride are the two main inputs. In our sample report para aminophenol is 70% of raw material cost and acetic anhydride 22%, with solvents and activated carbon making up the rest. Raw materials take 51.3% of sales, so para aminophenol price is the figure lenders test first.
Which licence is needed to manufacture paracetamol API?
You apply in Form 24 to the State Drugs Control Department and receive a manufacturing licence in Form 25 under the Drugs Rules, after an inspection. The plant must follow revised Schedule M good manufacturing practices. Bulk drugs also need prior environmental clearance under item 5(f) of the EIA Notification, 2006, and consents from the State Pollution Control Board.
Is a paracetamol API plant profitable?
In our illustrative sample, the plant earns a 13% return on investment in Year 3, breaks even at 43% of capacity and pays back in about 4.6 years. Margins are thinner than many specialty chemicals because paracetamol is a high-volume generic. Actual profit depends on para aminophenol buying, solvent recovery, yields and how quickly formulators approve you as a supplier.
Is a paracetamol API plant the same as a paracetamol tablet unit?
No. An API plant makes the bulk drug powder through chemical synthesis and falls under the bulk drug rules, including environmental clearance. A tablet unit buys that powder and compresses it into tablets, which is a formulation project with different machinery and approvals. NPCS prepares reports for both; this page and its sample cover the API plant.
Is the sample report free and can I use it for a loan?
The sample is free to view and download. It is an illustrative report that shows the format and depth of an NPCS report. Its figures are representative and not based on a real project, so it should not be submitted to a bank. For a loan, NPCS prepares a report for your own capacity, location and lender.
Sources and references
- Procedure for grant of drug manufacturing licence (Form 24 and Form 25)Drugs Control Authority, Andaman and Nicobar Administration, checked Oct 2026
- Extension of timeline for revised Schedule M (circular PXL/HO/Cir-087/2024-25)Pharmaceuticals Export Promotion Council of India, checked Oct 2026
- Activity 5(f): synthetic organic chemicals industry, standard terms of referenceMinistry of Environment, Forest and Climate Change, checked Oct 2026
- Categorisation of industrial sectors under Red as per CPCB criteriaState Pollution Control Board, Odisha, checked Oct 2026
- Release of the 10th edition of the Indian Pharmacopoeia (IP 2026)Indian Pharmacopoeia Commission, checked Oct 2026
- Update on PLI scheme for bulk drugs (as on 30.12.2022)Department of Pharmaceuticals, Government of India, checked Oct 2026
The NPCS project team, led by Ajay Kumar Gupta
This page and its sample report are prepared and reviewed by the NPCS project team, which has written techno-economic feasibility studies and detailed project reports since 1994.
Ajay Kumar Gupta founded Niir Project Consultancy Services (NPCS) and leads the organisation. With 40 years of experience in MSME project consulting, he has built the team that has delivered more than 28,000 project reports for clients worldwide, helping entrepreneurs plan and finance profitable manufacturing businesses.
- Published
- Last updated
- Next review
- Oct 2027
- Reviewed by
- NPCS project team
This page is reviewed every 12 months, or sooner when scheme limits, GST rates, BIS rules or pollution categories change. The sample report is illustrative: its figures are generated from industry-typical ratios for a unit of this size, checked so every statement balances, and are not taken from any client project.